Kevin Patrick Moran Vanda Pharmaceuticals Inc. (VNDA) insider trading activity

Kevin Patrick Moran is SVP, CFO & Treasurer of Vanda Pharmaceuticals Inc.. Currently has a direct ownership of 353,763 shares of VNDA, which is worth approximately $1.57 Million. The most recent transaction as insider was on Feb 18, 2025, when has been sold 125,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 354K

54.64% 3M change

43.97% 12M change

Total Value Held $1.57 Million

Kevin Patrick Moran Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 18 2025	BUY Grant, award, or other acquisition	-	125,000 Added 26.11%	353,763 Common Stock
Jul 29 2024	SELL Open market or private sale	$13,325 $5.92 p/Share	2,251 Reduced 0.97%	228,763 Common Stock
Mar 05 2024	SELL Open market or private sale	$37,388 $4.2 p/Share	8,902 Reduced 3.71%	231,014 Common Stock
Mar 04 2024	SELL Open market or private sale	$25,975 $4.48 p/Share	5,798 Reduced 2.36%	239,916 Common Stock
Feb 16 2024	BUY Grant, award, or other acquisition	-	125,000 Added 33.72%	245,714 Common Stock
Jul 28 2023	SELL Open market or private sale	$13,935 $6.3 p/Share	2,212 Reduced 1.8%	120,714 Common Stock
Jun 15 2023	SELL Open market or private sale	$100,640 $6.29 p/Share	16,000 Reduced 11.52%	122,926 Common Stock
Mar 03 2023	SELL Open market or private sale	$37,479 $6.28 p/Share	5,968 Reduced 4.12%	138,926 Common Stock
Mar 02 2023	SELL Open market or private sale	$49,867 $6.26 p/Share	7,966 Reduced 5.21%	144,894 Common Stock
Feb 16 2023	BUY Grant, award, or other acquisition	-	32,700 Added 17.62%	152,860 Common Stock
Dec 06 2022	SELL Open market or private sale	$50,843 $10.61 p/Share	4,792 Reduced 3.84%	120,160 Common Stock
Dec 06 2022	BUY Exercise of conversion of derivative security	$23,400 $3.12 p/Share	7,500 Added 5.66%	124,952 Common Stock
Jul 28 2022	SELL Open market or private sale	$24,562 $10.97 p/Share	2,239 Reduced 1.87%	117,452 Common Stock
Mar 02 2022	SELL Open market or private sale	$99,625 $11.28 p/Share	8,832 Reduced 6.87%	119,691 Common Stock
Mar 01 2022	SELL Open market or private sale	$38,863 $11.19 p/Share	3,473 Reduced 2.63%	128,523 Common Stock
Feb 28 2022	BUY Grant, award, or other acquisition	-	32,700 Added 19.85%	131,996 Common Stock
Jul 28 2021	SELL Open market or private sale	$40,981 $19.24 p/Share	2,130 Reduced 2.1%	99,296 Common Stock
Mar 02 2021	SELL Open market or private sale	$110,182 $18.23 p/Share	6,044 Reduced 5.62%	101,426 Common Stock
Mar 01 2021	SELL Open market or private sale	$61,782 $18.57 p/Share	3,327 Reduced 3.0%	107,470 Common Stock
Feb 24 2021	BUY Grant, award, or other acquisition	-	32,700 Added 22.79%	110,797 Common Stock

KPM

Kevin Patrick Moran

SVP, CFO & Treasurer

Washington, DC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VNDA shares.

Notify only if

Value

Insider Trading

Get notified when an Vanda Pharmaceuticals Inc. insider buys or sells VNDA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Vanda Pharmaceuticals Inc.

Track Activities on VNDA

Account